image stringlengths 20 66 | question stringclasses 16
values | answer stringlengths 3 10.7k |
|---|---|---|
PMC9415736_FIG8_386374.jpg | Describe the main subject of this image. | Microscopic view: pathological study confirms that the lesion is a dentigerous cystThe wall of the dentigerous cyst is lined by thin epithelial layers of undifferentiated cells, and the fibrous cyst wall is relatively inflamed. This is evident in parts a, b, and c of the image at different magnifications. Part d of the... |
PMC9415736_FIG8_386372.jpg | What is the focal point of this photograph? | Microscopic view: pathological study confirms that the lesion is a dentigerous cystThe wall of the dentigerous cyst is lined by thin epithelial layers of undifferentiated cells, and the fibrous cyst wall is relatively inflamed. This is evident in parts a, b, and c of the image at different magnifications. Part d of the... |
PMC9415736_FIG13_386376.jpg | What object or scene is depicted here? | Bone segment from the biopsy misdiagnosed as fibrous dysplasiaThis pathological diagnosis was not convincing for the medical staff because it is far from clinical findings. |
PMC9415738_pharmaceutics-14-01680-f012_386381.jpg | What is shown in this image? | Internalization of the NPs-PEG-Cy3 and NPs-Tmab-Cy3 bioconjugates by SKOV-3 cells determined by confocal microscopy. Cells treated and untreated (control) are shown as a reference. Fluorescence signals present: /1/ blue, nuclei localization; /2/ green, cytoskeleton; /3/ red, Cy3 modified NPs; /4/ merged photos. Magnifi... |
PMC9415738_pharmaceutics-14-01680-f012_386382.jpg | What is the principal component of this image? | Internalization of the NPs-PEG-Cy3 and NPs-Tmab-Cy3 bioconjugates by SKOV-3 cells determined by confocal microscopy. Cells treated and untreated (control) are shown as a reference. Fluorescence signals present: /1/ blue, nuclei localization; /2/ green, cytoskeleton; /3/ red, Cy3 modified NPs; /4/ merged photos. Magnifi... |
PMC9415738_pharmaceutics-14-01680-f012_386378.jpg | What is the core subject represented in this visual? | Internalization of the NPs-PEG-Cy3 and NPs-Tmab-Cy3 bioconjugates by SKOV-3 cells determined by confocal microscopy. Cells treated and untreated (control) are shown as a reference. Fluorescence signals present: /1/ blue, nuclei localization; /2/ green, cytoskeleton; /3/ red, Cy3 modified NPs; /4/ merged photos. Magnifi... |
PMC9415738_pharmaceutics-14-01680-f012_386377.jpg | What is shown in this image? | Internalization of the NPs-PEG-Cy3 and NPs-Tmab-Cy3 bioconjugates by SKOV-3 cells determined by confocal microscopy. Cells treated and untreated (control) are shown as a reference. Fluorescence signals present: /1/ blue, nuclei localization; /2/ green, cytoskeleton; /3/ red, Cy3 modified NPs; /4/ merged photos. Magnifi... |
PMC9415738_pharmaceutics-14-01680-f012_386383.jpg | What can you see in this picture? | Internalization of the NPs-PEG-Cy3 and NPs-Tmab-Cy3 bioconjugates by SKOV-3 cells determined by confocal microscopy. Cells treated and untreated (control) are shown as a reference. Fluorescence signals present: /1/ blue, nuclei localization; /2/ green, cytoskeleton; /3/ red, Cy3 modified NPs; /4/ merged photos. Magnifi... |
PMC9415738_pharmaceutics-14-01680-f012_386379.jpg | What stands out most in this visual? | Internalization of the NPs-PEG-Cy3 and NPs-Tmab-Cy3 bioconjugates by SKOV-3 cells determined by confocal microscopy. Cells treated and untreated (control) are shown as a reference. Fluorescence signals present: /1/ blue, nuclei localization; /2/ green, cytoskeleton; /3/ red, Cy3 modified NPs; /4/ merged photos. Magnifi... |
PMC9415738_pharmaceutics-14-01680-f012_386386.jpg | What is the principal component of this image? | Internalization of the NPs-PEG-Cy3 and NPs-Tmab-Cy3 bioconjugates by SKOV-3 cells determined by confocal microscopy. Cells treated and untreated (control) are shown as a reference. Fluorescence signals present: /1/ blue, nuclei localization; /2/ green, cytoskeleton; /3/ red, Cy3 modified NPs; /4/ merged photos. Magnifi... |
PMC9415738_pharmaceutics-14-01680-f012_386384.jpg | What is the dominant medical problem in this image? | Internalization of the NPs-PEG-Cy3 and NPs-Tmab-Cy3 bioconjugates by SKOV-3 cells determined by confocal microscopy. Cells treated and untreated (control) are shown as a reference. Fluorescence signals present: /1/ blue, nuclei localization; /2/ green, cytoskeleton; /3/ red, Cy3 modified NPs; /4/ merged photos. Magnifi... |
PMC9415795_materials-15-05615-f008_386391.jpg | What is the core subject represented in this visual? | Confocal microscopy visualization of MSCs cultured on PLA-d and PLA90/HA10-d for 21 days, labeled with Phalloidin® (green; cytoskeleton) and DAPI (blue; nucleus). Scale bars = 100 µm; insert = Scaffolds visualization in reflexion mode. The white dotted delimitations highlight the corresponding scaffold pores. |
PMC9415795_materials-15-05615-f008_386389.jpg | Describe the main subject of this image. | Confocal microscopy visualization of MSCs cultured on PLA-d and PLA90/HA10-d for 21 days, labeled with Phalloidin® (green; cytoskeleton) and DAPI (blue; nucleus). Scale bars = 100 µm; insert = Scaffolds visualization in reflexion mode. The white dotted delimitations highlight the corresponding scaffold pores. |
PMC9415801_nanomaterials-12-02742-f003_386393.jpg | What's the most prominent thing you notice in this picture? | Images of the FESEM morphologies using the magnification of ×200,000 to analyze Samples (A–E). The size of the white bars in each sub-image is 100 nm. Samples (A–E) show the nanoparticle structures, and Sample (F) shows a liquid-like structure. |
PMC9415801_nanomaterials-12-02742-f003_386392.jpg | What is the principal component of this image? | Images of the FESEM morphologies using the magnification of ×200,000 to analyze Samples (A–E). The size of the white bars in each sub-image is 100 nm. Samples (A–E) show the nanoparticle structures, and Sample (F) shows a liquid-like structure. |
PMC9415807_pharmaceuticals-15-01012-f011_386416.jpg | What can you see in this picture? | Photomicrographs (A–E): Transverse brain tissue sections from control NF group illustrating no histopathological alteration in: cerebral cortex (A); hippocampus (B); striatum (C); and substantia nigra (D,E) (arrows). Photomicrographs (F–J): transverse brain tissue sections from control PM animals’ cerebral cortex showe... |
PMC9415807_pharmaceuticals-15-01012-f011_386425.jpg | Can you identify the primary element in this image? | Photomicrographs (A–E): Transverse brain tissue sections from control NF group illustrating no histopathological alteration in: cerebral cortex (A); hippocampus (B); striatum (C); and substantia nigra (D,E) (arrows). Photomicrographs (F–J): transverse brain tissue sections from control PM animals’ cerebral cortex showe... |
PMC9415807_pharmaceuticals-15-01012-f011_386415.jpg | Can you identify the primary element in this image? | Photomicrographs (A–E): Transverse brain tissue sections from control NF group illustrating no histopathological alteration in: cerebral cortex (A); hippocampus (B); striatum (C); and substantia nigra (D,E) (arrows). Photomicrographs (F–J): transverse brain tissue sections from control PM animals’ cerebral cortex showe... |
PMC9415807_pharmaceuticals-15-01012-f011_386430.jpg | What is being portrayed in this visual content? | Photomicrographs (A–E): Transverse brain tissue sections from control NF group illustrating no histopathological alteration in: cerebral cortex (A); hippocampus (B); striatum (C); and substantia nigra (D,E) (arrows). Photomicrographs (F–J): transverse brain tissue sections from control PM animals’ cerebral cortex showe... |
PMC9415807_pharmaceuticals-15-01012-f011_386428.jpg | What is the core subject represented in this visual? | Photomicrographs (A–E): Transverse brain tissue sections from control NF group illustrating no histopathological alteration in: cerebral cortex (A); hippocampus (B); striatum (C); and substantia nigra (D,E) (arrows). Photomicrographs (F–J): transverse brain tissue sections from control PM animals’ cerebral cortex showe... |
PMC9415807_pharmaceuticals-15-01012-f011_386433.jpg | Can you identify the primary element in this image? | Photomicrographs (A–E): Transverse brain tissue sections from control NF group illustrating no histopathological alteration in: cerebral cortex (A); hippocampus (B); striatum (C); and substantia nigra (D,E) (arrows). Photomicrographs (F–J): transverse brain tissue sections from control PM animals’ cerebral cortex showe... |
PMC9415807_pharmaceuticals-15-01012-f011_386434.jpg | What object or scene is depicted here? | Photomicrographs (A–E): Transverse brain tissue sections from control NF group illustrating no histopathological alteration in: cerebral cortex (A); hippocampus (B); striatum (C); and substantia nigra (D,E) (arrows). Photomicrographs (F–J): transverse brain tissue sections from control PM animals’ cerebral cortex showe... |
PMC9415807_pharmaceuticals-15-01012-f011_386426.jpg | What is the dominant medical problem in this image? | Photomicrographs (A–E): Transverse brain tissue sections from control NF group illustrating no histopathological alteration in: cerebral cortex (A); hippocampus (B); striatum (C); and substantia nigra (D,E) (arrows). Photomicrographs (F–J): transverse brain tissue sections from control PM animals’ cerebral cortex showe... |
PMC9415807_pharmaceuticals-15-01012-f011_386420.jpg | What does this image primarily show? | Photomicrographs (A–E): Transverse brain tissue sections from control NF group illustrating no histopathological alteration in: cerebral cortex (A); hippocampus (B); striatum (C); and substantia nigra (D,E) (arrows). Photomicrographs (F–J): transverse brain tissue sections from control PM animals’ cerebral cortex showe... |
PMC9415807_pharmaceuticals-15-01012-f011_386429.jpg | What is the core subject represented in this visual? | Photomicrographs (A–E): Transverse brain tissue sections from control NF group illustrating no histopathological alteration in: cerebral cortex (A); hippocampus (B); striatum (C); and substantia nigra (D,E) (arrows). Photomicrographs (F–J): transverse brain tissue sections from control PM animals’ cerebral cortex showe... |
PMC9415807_pharmaceuticals-15-01012-f011_386427.jpg | What is the dominant medical problem in this image? | Photomicrographs (A–E): Transverse brain tissue sections from control NF group illustrating no histopathological alteration in: cerebral cortex (A); hippocampus (B); striatum (C); and substantia nigra (D,E) (arrows). Photomicrographs (F–J): transverse brain tissue sections from control PM animals’ cerebral cortex showe... |
PMC9415807_pharmaceuticals-15-01012-f011_386419.jpg | What does this image primarily show? | Photomicrographs (A–E): Transverse brain tissue sections from control NF group illustrating no histopathological alteration in: cerebral cortex (A); hippocampus (B); striatum (C); and substantia nigra (D,E) (arrows). Photomicrographs (F–J): transverse brain tissue sections from control PM animals’ cerebral cortex showe... |
PMC9415807_pharmaceuticals-15-01012-f011_386424.jpg | What is the dominant medical problem in this image? | Photomicrographs (A–E): Transverse brain tissue sections from control NF group illustrating no histopathological alteration in: cerebral cortex (A); hippocampus (B); striatum (C); and substantia nigra (D,E) (arrows). Photomicrographs (F–J): transverse brain tissue sections from control PM animals’ cerebral cortex showe... |
PMC9415807_pharmaceuticals-15-01012-f011_386423.jpg | What is the main focus of this visual representation? | Photomicrographs (A–E): Transverse brain tissue sections from control NF group illustrating no histopathological alteration in: cerebral cortex (A); hippocampus (B); striatum (C); and substantia nigra (D,E) (arrows). Photomicrographs (F–J): transverse brain tissue sections from control PM animals’ cerebral cortex showe... |
PMC9415807_pharmaceuticals-15-01012-f011_386431.jpg | What stands out most in this visual? | Photomicrographs (A–E): Transverse brain tissue sections from control NF group illustrating no histopathological alteration in: cerebral cortex (A); hippocampus (B); striatum (C); and substantia nigra (D,E) (arrows). Photomicrographs (F–J): transverse brain tissue sections from control PM animals’ cerebral cortex showe... |
PMC9415807_pharmaceuticals-15-01012-f011_386435.jpg | Describe the main subject of this image. | Photomicrographs (A–E): Transverse brain tissue sections from control NF group illustrating no histopathological alteration in: cerebral cortex (A); hippocampus (B); striatum (C); and substantia nigra (D,E) (arrows). Photomicrographs (F–J): transverse brain tissue sections from control PM animals’ cerebral cortex showe... |
PMC9415807_pharmaceuticals-15-01012-f011_386422.jpg | Can you identify the primary element in this image? | Photomicrographs (A–E): Transverse brain tissue sections from control NF group illustrating no histopathological alteration in: cerebral cortex (A); hippocampus (B); striatum (C); and substantia nigra (D,E) (arrows). Photomicrographs (F–J): transverse brain tissue sections from control PM animals’ cerebral cortex showe... |
PMC9415807_pharmaceuticals-15-01012-f012_386400.jpg | What is the central feature of this picture? | Photomicrographs (A–E): transverse brain tissue sections from MH treated-PM animals show no histopathological alteration in cerebral cortex (A) (arrows), hippocampus (subiculum, fascia dentate and hilus) (B,C) (arrows), striatum and substantia nigra (D,E) (arrows). Photomicrographs (F–J): Transverse brain tissue sectio... |
PMC9415807_pharmaceuticals-15-01012-f012_386409.jpg | What stands out most in this visual? | Photomicrographs (A–E): transverse brain tissue sections from MH treated-PM animals show no histopathological alteration in cerebral cortex (A) (arrows), hippocampus (subiculum, fascia dentate and hilus) (B,C) (arrows), striatum and substantia nigra (D,E) (arrows). Photomicrographs (F–J): Transverse brain tissue sectio... |
PMC9415807_pharmaceuticals-15-01012-f012_386413.jpg | What is shown in this image? | Photomicrographs (A–E): transverse brain tissue sections from MH treated-PM animals show no histopathological alteration in cerebral cortex (A) (arrows), hippocampus (subiculum, fascia dentate and hilus) (B,C) (arrows), striatum and substantia nigra (D,E) (arrows). Photomicrographs (F–J): Transverse brain tissue sectio... |
PMC9415807_pharmaceuticals-15-01012-f012_386404.jpg | What is the core subject represented in this visual? | Photomicrographs (A–E): transverse brain tissue sections from MH treated-PM animals show no histopathological alteration in cerebral cortex (A) (arrows), hippocampus (subiculum, fascia dentate and hilus) (B,C) (arrows), striatum and substantia nigra (D,E) (arrows). Photomicrographs (F–J): Transverse brain tissue sectio... |
PMC9415807_pharmaceuticals-15-01012-f012_386401.jpg | What's the most prominent thing you notice in this picture? | Photomicrographs (A–E): transverse brain tissue sections from MH treated-PM animals show no histopathological alteration in cerebral cortex (A) (arrows), hippocampus (subiculum, fascia dentate and hilus) (B,C) (arrows), striatum and substantia nigra (D,E) (arrows). Photomicrographs (F–J): Transverse brain tissue sectio... |
PMC9415807_pharmaceuticals-15-01012-f012_386412.jpg | What stands out most in this visual? | Photomicrographs (A–E): transverse brain tissue sections from MH treated-PM animals show no histopathological alteration in cerebral cortex (A) (arrows), hippocampus (subiculum, fascia dentate and hilus) (B,C) (arrows), striatum and substantia nigra (D,E) (arrows). Photomicrographs (F–J): Transverse brain tissue sectio... |
PMC9415807_pharmaceuticals-15-01012-f012_386410.jpg | What key item or scene is captured in this photo? | Photomicrographs (A–E): transverse brain tissue sections from MH treated-PM animals show no histopathological alteration in cerebral cortex (A) (arrows), hippocampus (subiculum, fascia dentate and hilus) (B,C) (arrows), striatum and substantia nigra (D,E) (arrows). Photomicrographs (F–J): Transverse brain tissue sectio... |
PMC9415807_pharmaceuticals-15-01012-f012_386405.jpg | What's the most prominent thing you notice in this picture? | Photomicrographs (A–E): transverse brain tissue sections from MH treated-PM animals show no histopathological alteration in cerebral cortex (A) (arrows), hippocampus (subiculum, fascia dentate and hilus) (B,C) (arrows), striatum and substantia nigra (D,E) (arrows). Photomicrographs (F–J): Transverse brain tissue sectio... |
PMC9415807_pharmaceuticals-15-01012-f012_386403.jpg | What key item or scene is captured in this photo? | Photomicrographs (A–E): transverse brain tissue sections from MH treated-PM animals show no histopathological alteration in cerebral cortex (A) (arrows), hippocampus (subiculum, fascia dentate and hilus) (B,C) (arrows), striatum and substantia nigra (D,E) (arrows). Photomicrographs (F–J): Transverse brain tissue sectio... |
PMC9415807_pharmaceuticals-15-01012-f012_386402.jpg | What object or scene is depicted here? | Photomicrographs (A–E): transverse brain tissue sections from MH treated-PM animals show no histopathological alteration in cerebral cortex (A) (arrows), hippocampus (subiculum, fascia dentate and hilus) (B,C) (arrows), striatum and substantia nigra (D,E) (arrows). Photomicrographs (F–J): Transverse brain tissue sectio... |
PMC9415807_pharmaceuticals-15-01012-f012_386407.jpg | What stands out most in this visual? | Photomicrographs (A–E): transverse brain tissue sections from MH treated-PM animals show no histopathological alteration in cerebral cortex (A) (arrows), hippocampus (subiculum, fascia dentate and hilus) (B,C) (arrows), striatum and substantia nigra (D,E) (arrows). Photomicrographs (F–J): Transverse brain tissue sectio... |
PMC9415807_pharmaceuticals-15-01012-f012_386414.jpg | What is being portrayed in this visual content? | Photomicrographs (A–E): transverse brain tissue sections from MH treated-PM animals show no histopathological alteration in cerebral cortex (A) (arrows), hippocampus (subiculum, fascia dentate and hilus) (B,C) (arrows), striatum and substantia nigra (D,E) (arrows). Photomicrographs (F–J): Transverse brain tissue sectio... |
PMC9415808_microorganisms-10-01553-f002_386397.jpg | What key item or scene is captured in this photo? | Scanning electron microscopy observation of the interaction between H. anguillulae YMF 1.01751 and P. redivivus. (A) The coculture of H. anguillulae YMF 1.01751 and P. redivivus. (B) The hyphae begin to grow through nematode body. (C,D) A lot of hyphae continue to grow through the body wall. (E,F) The nematode was fina... |
PMC9415808_microorganisms-10-01553-f002_386398.jpg | What object or scene is depicted here? | Scanning electron microscopy observation of the interaction between H. anguillulae YMF 1.01751 and P. redivivus. (A) The coculture of H. anguillulae YMF 1.01751 and P. redivivus. (B) The hyphae begin to grow through nematode body. (C,D) A lot of hyphae continue to grow through the body wall. (E,F) The nematode was fina... |
PMC9415808_microorganisms-10-01553-f002_386396.jpg | What is shown in this image? | Scanning electron microscopy observation of the interaction between H. anguillulae YMF 1.01751 and P. redivivus. (A) The coculture of H. anguillulae YMF 1.01751 and P. redivivus. (B) The hyphae begin to grow through nematode body. (C,D) A lot of hyphae continue to grow through the body wall. (E,F) The nematode was fina... |
PMC9415808_microorganisms-10-01553-f002_386399.jpg | Describe the main subject of this image. | Scanning electron microscopy observation of the interaction between H. anguillulae YMF 1.01751 and P. redivivus. (A) The coculture of H. anguillulae YMF 1.01751 and P. redivivus. (B) The hyphae begin to grow through nematode body. (C,D) A lot of hyphae continue to grow through the body wall. (E,F) The nematode was fina... |
PMC9415808_microorganisms-10-01553-f002_386395.jpg | What can you see in this picture? | Scanning electron microscopy observation of the interaction between H. anguillulae YMF 1.01751 and P. redivivus. (A) The coculture of H. anguillulae YMF 1.01751 and P. redivivus. (B) The hyphae begin to grow through nematode body. (C,D) A lot of hyphae continue to grow through the body wall. (E,F) The nematode was fina... |
PMC9415808_microorganisms-10-01553-f002_386394.jpg | What is being portrayed in this visual content? | Scanning electron microscopy observation of the interaction between H. anguillulae YMF 1.01751 and P. redivivus. (A) The coculture of H. anguillulae YMF 1.01751 and P. redivivus. (B) The hyphae begin to grow through nematode body. (C,D) A lot of hyphae continue to grow through the body wall. (E,F) The nematode was fina... |
PMC9415811_materials-15-05625-f009_386437.jpg | What can you see in this picture? | SEM observations of cryogenic fracture of PVC hybrid filler composites. (A) PVC 5CF/CNT-PVAc - mag. 500× (B) PVC 10CF/CNT-PVAc - mag. 500× (C) fibre–matrix interface - mag. 5 k× (D) fibre–matrix interface mag. 10 k×. |
PMC9415817_materials-15-05560-f012_386446.jpg | What can you see in this picture? | Factography of titanium aluminide samples: (a) Morphology of the fracture surface of sample MA-20; (b) Morphology of the fracture surface of sample MA-180. |
PMC9415817_materials-15-05560-f012_386445.jpg | What is the principal component of this image? | Factography of titanium aluminide samples: (a) Morphology of the fracture surface of sample MA-20; (b) Morphology of the fracture surface of sample MA-180. |
PMC9415817_materials-15-05560-f012_386444.jpg | What is the focal point of this photograph? | Factography of titanium aluminide samples: (a) Morphology of the fracture surface of sample MA-20; (b) Morphology of the fracture surface of sample MA-180. |
PMC9415817_materials-15-05560-f012_386447.jpg | Describe the main subject of this image. | Factography of titanium aluminide samples: (a) Morphology of the fracture surface of sample MA-20; (b) Morphology of the fracture surface of sample MA-180. |
PMC9415817_materials-15-05560-f013_386443.jpg | What can you see in this picture? | Fractography of titanium aluminide samples after heat treatment. |
PMC9415817_materials-15-05560-f013_386440.jpg | What does this image primarily show? | Fractography of titanium aluminide samples after heat treatment. |
PMC9415817_materials-15-05560-f013_386441.jpg | What does this image primarily show? | Fractography of titanium aluminide samples after heat treatment. |
PMC9415817_materials-15-05560-f013_386442.jpg | What is being portrayed in this visual content? | Fractography of titanium aluminide samples after heat treatment. |
PMC9415825_micromachines-13-01312-f008_386448.jpg | What is the central feature of this picture? | A demonstration of copper patterning. (a,b) Metal deposition by scanning the bubble injector in a I and S shape. |
PMC9415825_micromachines-13-01312-f008_386449.jpg | What is the principal component of this image? | A demonstration of copper patterning. (a,b) Metal deposition by scanning the bubble injector in a I and S shape. |
PMC9415831_membranes-12-00787-f005_386455.jpg | What is the core subject represented in this visual? | Representative SEM images of the test membranes without degradation (left; magnification, 5000×) and after degradation (right, 15,000×; 1.5 h for NCL-E and 12 h for NCL-P and ECL-E). Please note the sperm cells, which are visible and trying to pass through the collagen fibers and different pores. |
PMC9415831_membranes-12-00787-f005_386452.jpg | What does this image primarily show? | Representative SEM images of the test membranes without degradation (left; magnification, 5000×) and after degradation (right, 15,000×; 1.5 h for NCL-E and 12 h for NCL-P and ECL-E). Please note the sperm cells, which are visible and trying to pass through the collagen fibers and different pores. |
PMC9415831_membranes-12-00787-f005_386453.jpg | Can you identify the primary element in this image? | Representative SEM images of the test membranes without degradation (left; magnification, 5000×) and after degradation (right, 15,000×; 1.5 h for NCL-E and 12 h for NCL-P and ECL-E). Please note the sperm cells, which are visible and trying to pass through the collagen fibers and different pores. |
PMC9415831_membranes-12-00787-f005_386451.jpg | What is the core subject represented in this visual? | Representative SEM images of the test membranes without degradation (left; magnification, 5000×) and after degradation (right, 15,000×; 1.5 h for NCL-E and 12 h for NCL-P and ECL-E). Please note the sperm cells, which are visible and trying to pass through the collagen fibers and different pores. |
PMC9415831_membranes-12-00787-f005_386450.jpg | What is the central feature of this picture? | Representative SEM images of the test membranes without degradation (left; magnification, 5000×) and after degradation (right, 15,000×; 1.5 h for NCL-E and 12 h for NCL-P and ECL-E). Please note the sperm cells, which are visible and trying to pass through the collagen fibers and different pores. |
PMC9415831_membranes-12-00787-f005_386454.jpg | What is being portrayed in this visual content? | Representative SEM images of the test membranes without degradation (left; magnification, 5000×) and after degradation (right, 15,000×; 1.5 h for NCL-E and 12 h for NCL-P and ECL-E). Please note the sperm cells, which are visible and trying to pass through the collagen fibers and different pores. |
PMC9415833_viruses-14-01643-f001_386456.jpg | Can you identify the primary element in this image? | Clinical characteristics of diseased largemouth bass. (A) Ulcer lesions on the body surface (white arrows), (B) lesions in the viscera (white arrows), and (C) bleeding and necrosis lesions on the gills (white arrows). |
PMC9415833_viruses-14-01643-f001_386457.jpg | What stands out most in this visual? | Clinical characteristics of diseased largemouth bass. (A) Ulcer lesions on the body surface (white arrows), (B) lesions in the viscera (white arrows), and (C) bleeding and necrosis lesions on the gills (white arrows). |
PMC9415842_vetsci-09-00445-f004_386459.jpg | What object or scene is depicted here? | Representative histological images from: (A) Caiman5 group, (B) Caiman Maryland group, (C) Caiman12 group (D) Ligasure Atlas group). H&E stain. The images were obtained by combining several 4X magnification fields of view. Black arrow shows the fusion line. (s) serosa; (m) muscolaris; (sm) submucosa; (mu) mucosa. Yello... |
PMC9415842_vetsci-09-00445-f004_386461.jpg | What is the dominant medical problem in this image? | Representative histological images from: (A) Caiman5 group, (B) Caiman Maryland group, (C) Caiman12 group (D) Ligasure Atlas group). H&E stain. The images were obtained by combining several 4X magnification fields of view. Black arrow shows the fusion line. (s) serosa; (m) muscolaris; (sm) submucosa; (mu) mucosa. Yello... |
PMC9415842_vetsci-09-00445-f004_386458.jpg | What object or scene is depicted here? | Representative histological images from: (A) Caiman5 group, (B) Caiman Maryland group, (C) Caiman12 group (D) Ligasure Atlas group). H&E stain. The images were obtained by combining several 4X magnification fields of view. Black arrow shows the fusion line. (s) serosa; (m) muscolaris; (sm) submucosa; (mu) mucosa. Yello... |
PMC9415843_pharmaceutics-14-01612-f005_386466.jpg | What is the central feature of this picture? | MicroSPECT/CT imaging of HER2-expression in mice from the PBS group using 99mTc(CO)3-ADAPT6-ABD-mcDM1 at (A) 4 h and (B) 24 h p.i., (C) using 99mTc(CO)3-ADAPT6 at 4 h p.i. and (D) using 99mTc-ZHER2:41071 at 4 h p.i. The arrows with the letters “T”, “K”, “L” and “B” point to the tumors, kidneys, liver and blood pool in ... |
PMC9415843_pharmaceutics-14-01612-f005_386469.jpg | What is the dominant medical problem in this image? | MicroSPECT/CT imaging of HER2-expression in mice from the PBS group using 99mTc(CO)3-ADAPT6-ABD-mcDM1 at (A) 4 h and (B) 24 h p.i., (C) using 99mTc(CO)3-ADAPT6 at 4 h p.i. and (D) using 99mTc-ZHER2:41071 at 4 h p.i. The arrows with the letters “T”, “K”, “L” and “B” point to the tumors, kidneys, liver and blood pool in ... |
PMC9415843_pharmaceutics-14-01612-f005_386468.jpg | What stands out most in this visual? | MicroSPECT/CT imaging of HER2-expression in mice from the PBS group using 99mTc(CO)3-ADAPT6-ABD-mcDM1 at (A) 4 h and (B) 24 h p.i., (C) using 99mTc(CO)3-ADAPT6 at 4 h p.i. and (D) using 99mTc-ZHER2:41071 at 4 h p.i. The arrows with the letters “T”, “K”, “L” and “B” point to the tumors, kidneys, liver and blood pool in ... |
PMC9415843_pharmaceutics-14-01612-f006_386462.jpg | What is the focal point of this photograph? | MicroSPECT/CT imaging of HER2-expression using 99mTc-ZHER2:41071 in BALB/c nu/nu mice bearing SKOV3 xenografts. The imaging was performed at days 43 (A), 29 (B), 34 (C) and 77 (D) of the experimental therapy. Two mice from the ADAPT6-ABD-mcDM1 treated group with small tumors at day 43 (A) and day 77 (D), two mice from ... |
PMC9415843_pharmaceutics-14-01612-f006_386465.jpg | What is the dominant medical problem in this image? | MicroSPECT/CT imaging of HER2-expression using 99mTc-ZHER2:41071 in BALB/c nu/nu mice bearing SKOV3 xenografts. The imaging was performed at days 43 (A), 29 (B), 34 (C) and 77 (D) of the experimental therapy. Two mice from the ADAPT6-ABD-mcDM1 treated group with small tumors at day 43 (A) and day 77 (D), two mice from ... |
PMC9415843_pharmaceutics-14-01612-f006_386463.jpg | What is the central feature of this picture? | MicroSPECT/CT imaging of HER2-expression using 99mTc-ZHER2:41071 in BALB/c nu/nu mice bearing SKOV3 xenografts. The imaging was performed at days 43 (A), 29 (B), 34 (C) and 77 (D) of the experimental therapy. Two mice from the ADAPT6-ABD-mcDM1 treated group with small tumors at day 43 (A) and day 77 (D), two mice from ... |
PMC9415843_pharmaceutics-14-01612-f006_386464.jpg | What is being portrayed in this visual content? | MicroSPECT/CT imaging of HER2-expression using 99mTc-ZHER2:41071 in BALB/c nu/nu mice bearing SKOV3 xenografts. The imaging was performed at days 43 (A), 29 (B), 34 (C) and 77 (D) of the experimental therapy. Two mice from the ADAPT6-ABD-mcDM1 treated group with small tumors at day 43 (A) and day 77 (D), two mice from ... |
PMC9415854_pathogens-11-00884-f001_386479.jpg | Describe the main subject of this image. | Pictorial representation symptoms of anthracnose disease. (A) Healthy; (B) grade 1: small white specks; (C) grade 2: initial chlorosis; (D) grade 3: advancement of lesion; (E) grade 4: mature lesion; (F) grade 5: lesions begin to coalesce; (G) grade 6: advanced lesion leading to death of leaf blades; (H) grade 7: most ... |
PMC9415854_pathogens-11-00884-f001_386476.jpg | What stands out most in this visual? | Pictorial representation symptoms of anthracnose disease. (A) Healthy; (B) grade 1: small white specks; (C) grade 2: initial chlorosis; (D) grade 3: advancement of lesion; (E) grade 4: mature lesion; (F) grade 5: lesions begin to coalesce; (G) grade 6: advanced lesion leading to death of leaf blades; (H) grade 7: most ... |
PMC9415854_pathogens-11-00884-f001_386473.jpg | What is the principal component of this image? | Pictorial representation symptoms of anthracnose disease. (A) Healthy; (B) grade 1: small white specks; (C) grade 2: initial chlorosis; (D) grade 3: advancement of lesion; (E) grade 4: mature lesion; (F) grade 5: lesions begin to coalesce; (G) grade 6: advanced lesion leading to death of leaf blades; (H) grade 7: most ... |
PMC9415854_pathogens-11-00884-f001_386478.jpg | What does this image primarily show? | Pictorial representation symptoms of anthracnose disease. (A) Healthy; (B) grade 1: small white specks; (C) grade 2: initial chlorosis; (D) grade 3: advancement of lesion; (E) grade 4: mature lesion; (F) grade 5: lesions begin to coalesce; (G) grade 6: advanced lesion leading to death of leaf blades; (H) grade 7: most ... |
PMC9415854_pathogens-11-00884-f001_386472.jpg | What object or scene is depicted here? | Pictorial representation symptoms of anthracnose disease. (A) Healthy; (B) grade 1: small white specks; (C) grade 2: initial chlorosis; (D) grade 3: advancement of lesion; (E) grade 4: mature lesion; (F) grade 5: lesions begin to coalesce; (G) grade 6: advanced lesion leading to death of leaf blades; (H) grade 7: most ... |
PMC9415854_pathogens-11-00884-f001_386474.jpg | What is the dominant medical problem in this image? | Pictorial representation symptoms of anthracnose disease. (A) Healthy; (B) grade 1: small white specks; (C) grade 2: initial chlorosis; (D) grade 3: advancement of lesion; (E) grade 4: mature lesion; (F) grade 5: lesions begin to coalesce; (G) grade 6: advanced lesion leading to death of leaf blades; (H) grade 7: most ... |
PMC9415897_micromachines-13-01319-f010_386482.jpg | Can you identify the primary element in this image? | Three-dimensional printed sodium alginate gel cylinders prior to crosslinking. |
PMC9415897_micromachines-13-01319-f010_386483.jpg | What object or scene is depicted here? | Three-dimensional printed sodium alginate gel cylinders prior to crosslinking. |
PMC9415897_micromachines-13-01319-f011_386480.jpg | What object or scene is depicted here? | Free-standing 3D printed sodium alginate gel cylinders as the model mechanoresponsive system. |
PMC9415897_micromachines-13-01319-f011_386481.jpg | What can you see in this picture? | Free-standing 3D printed sodium alginate gel cylinders as the model mechanoresponsive system. |
PMC9415909_materials-15-05648-f004_386484.jpg | What's the most prominent thing you notice in this picture? | PAFC casting procedure (a) mold filled with aggregates and fibers, (b) grout injection, (c) GFM placement, (d) finished specimens. |
PMC9415909_materials-15-05648-f004_386486.jpg | What is the principal component of this image? | PAFC casting procedure (a) mold filled with aggregates and fibers, (b) grout injection, (c) GFM placement, (d) finished specimens. |
PMC9415909_materials-15-05648-f004_386485.jpg | Describe the main subject of this image. | PAFC casting procedure (a) mold filled with aggregates and fibers, (b) grout injection, (c) GFM placement, (d) finished specimens. |
PMC9415909_materials-15-05648-f015_386489.jpg | What object or scene is depicted here? | Failure pattern of PAFC. (a) CC, (b) G2-50, (c) G2-75, (d) G2-100, (e) G2-125, (f) G2-150, (g) FC, (h) FG2-50, (i) FG2-75, (j) FG2-100, (k) FG2-125 and (l) FG2-150. |
PMC9415909_materials-15-05648-f015_386492.jpg | What's the most prominent thing you notice in this picture? | Failure pattern of PAFC. (a) CC, (b) G2-50, (c) G2-75, (d) G2-100, (e) G2-125, (f) G2-150, (g) FC, (h) FG2-50, (i) FG2-75, (j) FG2-100, (k) FG2-125 and (l) FG2-150. |
PMC9415909_materials-15-05648-f015_386488.jpg | What key item or scene is captured in this photo? | Failure pattern of PAFC. (a) CC, (b) G2-50, (c) G2-75, (d) G2-100, (e) G2-125, (f) G2-150, (g) FC, (h) FG2-50, (i) FG2-75, (j) FG2-100, (k) FG2-125 and (l) FG2-150. |
PMC9415909_materials-15-05648-f015_386491.jpg | What object or scene is depicted here? | Failure pattern of PAFC. (a) CC, (b) G2-50, (c) G2-75, (d) G2-100, (e) G2-125, (f) G2-150, (g) FC, (h) FG2-50, (i) FG2-75, (j) FG2-100, (k) FG2-125 and (l) FG2-150. |
PMC9415909_materials-15-05648-f015_386490.jpg | What is shown in this image? | Failure pattern of PAFC. (a) CC, (b) G2-50, (c) G2-75, (d) G2-100, (e) G2-125, (f) G2-150, (g) FC, (h) FG2-50, (i) FG2-75, (j) FG2-100, (k) FG2-125 and (l) FG2-150. |
PMC9415929_medicina-58-01077-f002_386496.jpg | What is the principal component of this image? | Representative endoscopic images of gastroesophageal varices. (A): Normal; (B): Normal, (C): F1RC0, (D): F1RC0, (E): F2RC0, (F): F2RC1. |
PMC9415929_medicina-58-01077-f002_386499.jpg | What can you see in this picture? | Representative endoscopic images of gastroesophageal varices. (A): Normal; (B): Normal, (C): F1RC0, (D): F1RC0, (E): F2RC0, (F): F2RC1. |
PMC9415929_medicina-58-01077-f002_386498.jpg | Describe the main subject of this image. | Representative endoscopic images of gastroesophageal varices. (A): Normal; (B): Normal, (C): F1RC0, (D): F1RC0, (E): F2RC0, (F): F2RC1. |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.